Evidence map›Paper›PMID 26366391›Full record

ArticleAnnals of translational medicine2015

The CRISPR road: from bench to bedside on an RNA-guided path.

Benjamin Garcia-Bloj, Colette Moses, Pilar Blancafort

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of translational medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Benjamin Garcia-Bloj1 Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Nedlands, Western Australia 6009, Australia ; 2 School of Medicine, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile ; 3 School of Anatomy, Physiology and Human Biology, Faculty of Life and Physical Sciences, The University of Western Australia, Crawley, Western Australia 6009, Australia.
Colette Moses1 Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Nedlands, Western Australia 6009, Australia ; 2 School of Medicine, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile ; 3 School of Anatomy, Physiology and Human Biology, Faculty of Life and Physical Sciences, The University of Western Australia, Crawley, Western Australia 6009, Australia.
Pilar Blancafort1 Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Nedlands, Western Australia 6009, Australia ; 2 School of Medicine, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile ; 3 School of Anatomy, Physiology and Human Biology, Faculty of Life and Physical Sciences, The University of Western Australia, Crawley, Western Australia 6009, Australia.

Funding

Targeted epigenetic silencing of oncogenic Transcription Factors (PQ18)R01CA170370 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BLANCAFORT, PILAR · 2012 to 2015
$900k
Precision engineering of DNA methylation patterns in the human genomeR01DA036906 · NIDA · UNIVERSITY OF WESTERN AUSTRALIA · PI BLANCAFORT, PILAR, LISTER, RYAN · 2013 to 2014
$350k
NCI NIH HHS R01 CA170370NIDA NIH HHS R01 DA036906
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID26366391
PMCPMC4543326

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.